Advertisement

Topics

The NASDAQ capitals markets, how suitable are they for your organisation?

19:00 EDT 7 Oct 2015 | PharmaTelevision

Adam Korstyal, Senior Vice President, NASDAQ, speaks to Fintan Walton, CEO of PharmaVentures, about the benefits of listing a Biotech company on the NASDAQ stock exchange. They distinguish between NASDAQ First North, NASDAQ North West and the main NASDAQ Market in the USA. They give insight on the kinds of preparation Biotech companies should make when considering launching an IPO.

Original Article: The NASDAQ capitals markets, how suitable are they for your organisation?

NEXT ARTICLE

More From BioPortfolio on "The NASDAQ capitals markets, how suitable are they for your organisation?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...